Search research articles
Contact Us
Filters
Showing results (391-400 of 480) with videos related to
Page
of 48
Sort By:
International Journal of Geriatric Psychiatry
|
May 6, 2017
Feasibility of a staff training and support programme to improve pain assessment and management in people with dementia living in care homes
Anya Petyaeva, Martine Kajander, Vanessa Lawrence, et al.
International Journal of Geriatric Psychiatry
|
September 20, 2016
Impact of antipsychotic review and non-pharmacological intervention on health-related quality of life in people with dementia living in care homes: WHELD-a factorial cluster randomised controlled trial
Clive Ballard, Martin Orrell, Yongzhong Sun, et al.
The Journal of Pharmacy and Pharmacology
|
October 30, 2008
Pharmacological profile of essential oils derived from Lavandula angustifolia and Melissa officinalis with anti-agitation properties: focus on ligand-gated channels
Liping Huang, Sawsan Abuhamdah, Melanie-Jayne R Howes, et al.
The New England Journal of Medicine
|
July 21, 2021
Trial of Pimavanserin in Dementia-Related Psychosis
Pierre N Tariot, Jeffrey L Cummings, Maria E Soto-Martin, et al.
The American Journal of Geriatric Psychiatry : Official Journal of the American Association for Geriatric Psychiatry
|
November 13, 2022
A Randomised Placebo-Controlled Study of Purified Anthocyanins on Cognition in Individuals at Increased Risk for Dementia
Dag Aarsland, Khadija Khalifa, Anne K Bergland, et al.
Brain Pathology (Zurich, Switzerland)
|
July 18, 2023
Decreased DHA-containing phospholipids in the neocortex of dementia with Lewy bodies are associated with soluble Aβ<sub>42</sub> , phosphorylated α-synuclein, and synaptopathology
Joyce R Chong, Yuek Ling Chai, Huayang Xing, et al.
Plos One
|
January 18, 2017
Intensive versus Guideline Blood Pressure and Lipid Lowering in Patients with Previous Stroke: Main Results from the Pilot 'Prevention of Decline in Cognition after Stroke Trial' (PODCAST) Randomised Controlled Trial
Philip M Bath, Polly Scutt, Daniel J Blackburn, et al.
Journal of the American Medical Directors Association
|
December 20, 2014
A double-blind randomized placebo-controlled withdrawal trial comparing memantine and antipsychotics for the long-term treatment of function and neuropsychiatric symptoms in people with Alzheimer's disease (MAIN-AD)
Clive Ballard, Alan Thomas, Stephen Gerry, et al.
BMC Neurology
|
September 9, 2019
Study protocol: ASCRIBED: the impact of Acute SystematiC inflammation upon cerebRospinal fluId and blood BiomarkErs of brain inflammation and injury in dementia: a study in acute hip fracture patients
Nick Leavey, Simon P Hammond, Lee Shepstone, et al.
Movement Disorders : Official Journal of the Movement Disorder Society
|
November 3, 2018
Pimavanserin for Parkinson's Disease psychosis: Effects stratified by baseline cognition and use of cognitive-enhancing medications
Alberto J Espay, Michael T Guskey, James C Norton, et al.
Page
of 48
Search research articles
Search
Showing results (391-400 of 480) with videos related to
Sort By:
Page
of 48
International Journal of Geriatric Psychiatry
|
May 6, 2017
Feasibility of a staff training and support programme to improve pain assessment and management in people with dementia living in care homes
Anya Petyaeva, Martine Kajander, Vanessa Lawrence, et al.
International Journal of Geriatric Psychiatry
|
September 20, 2016
Impact of antipsychotic review and non-pharmacological intervention on health-related quality of life in people with dementia living in care homes: WHELD-a factorial cluster randomised controlled trial
Clive Ballard, Martin Orrell, Yongzhong Sun, et al.
The Journal of Pharmacy and Pharmacology
|
October 30, 2008
Pharmacological profile of essential oils derived from Lavandula angustifolia and Melissa officinalis with anti-agitation properties: focus on ligand-gated channels
Liping Huang, Sawsan Abuhamdah, Melanie-Jayne R Howes, et al.
The New England Journal of Medicine
|
July 21, 2021
Trial of Pimavanserin in Dementia-Related Psychosis
Pierre N Tariot, Jeffrey L Cummings, Maria E Soto-Martin, et al.
The American Journal of Geriatric Psychiatry : Official Journal of the American Association for Geriatric Psychiatry
|
November 13, 2022
A Randomised Placebo-Controlled Study of Purified Anthocyanins on Cognition in Individuals at Increased Risk for Dementia
Dag Aarsland, Khadija Khalifa, Anne K Bergland, et al.
Brain Pathology (Zurich, Switzerland)
|
July 18, 2023
Decreased DHA-containing phospholipids in the neocortex of dementia with Lewy bodies are associated with soluble Aβ<sub>42</sub> , phosphorylated α-synuclein, and synaptopathology
Joyce R Chong, Yuek Ling Chai, Huayang Xing, et al.
Plos One
|
January 18, 2017
Intensive versus Guideline Blood Pressure and Lipid Lowering in Patients with Previous Stroke: Main Results from the Pilot 'Prevention of Decline in Cognition after Stroke Trial' (PODCAST) Randomised Controlled Trial
Philip M Bath, Polly Scutt, Daniel J Blackburn, et al.
Journal of the American Medical Directors Association
|
December 20, 2014
A double-blind randomized placebo-controlled withdrawal trial comparing memantine and antipsychotics for the long-term treatment of function and neuropsychiatric symptoms in people with Alzheimer's disease (MAIN-AD)
Clive Ballard, Alan Thomas, Stephen Gerry, et al.
BMC Neurology
|
September 9, 2019
Study protocol: ASCRIBED: the impact of Acute SystematiC inflammation upon cerebRospinal fluId and blood BiomarkErs of brain inflammation and injury in dementia: a study in acute hip fracture patients
Nick Leavey, Simon P Hammond, Lee Shepstone, et al.
Movement Disorders : Official Journal of the Movement Disorder Society
|
November 3, 2018
Pimavanserin for Parkinson's Disease psychosis: Effects stratified by baseline cognition and use of cognitive-enhancing medications
Alberto J Espay, Michael T Guskey, James C Norton, et al.
Page
of 48